Mario Schlosser Sells 150,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 150,000 shares of the firm’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $30.79, for a total value of $4,618,500.00. Following the completion of the sale, the director directly owned 480,866 shares of the company’s stock, valued at $14,805,864.14. This represents a 23.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $748,592.80.

Oscar Health Trading Down 0.4%

Shares of Oscar Health stock opened at $29.84 on Wednesday. The stock has a market capitalization of $9.21 billion, a P/E ratio of 21.31, a P/E/G ratio of 0.62 and a beta of 2.37. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $33.55. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The stock’s 50-day simple moving average is $30.29 and its 200 day simple moving average is $22.36.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s quarterly revenue was up 70.4% on a year-over-year basis. During the same quarter last year, the business earned ($0.89) earnings per share. As a group, research analysts anticipate that Oscar Health, Inc. will post 1.54 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in OSCR. California State Teachers Retirement System increased its holdings in shares of Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock worth $222,543,000 after purchasing an additional 7,567,600 shares during the period. Comprehensive Financial Planning Inc. PA purchased a new position in Oscar Health during the second quarter worth about $309,000. AXQ Capital LP purchased a new position in Oscar Health during the second quarter worth about $1,059,000. Nykredit A S bought a new position in Oscar Health in the 2nd quarter worth about $130,000. Finally, Wellington Management Group LLP increased its stake in Oscar Health by 65.6% in the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock worth $17,217,000 after acquiring an additional 239,109 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. UBS Group lifted their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Wolfe Research started coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. The Goldman Sachs Group reiterated a “neutral” rating and set a $30.00 price objective on shares of Oscar Health in a research note on Tuesday, August 11th. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, Oscar Health presently has an average rating of “Hold” and a consensus price target of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.